Knowledge, attitude, and perception of University students toward COVID-19 Pandemic
Keywords:COVID-19, knowledge, attitude, perception, Awareness, social media campaign
Background: An increasing rate of COVID-19 cases throughout the world has increased the need to investigate the knowledge, attitude, and perception (KAP) of university students toward the COVID-19 pandemic to prevent its rapid spread as public cooperation and awareness regarding prevention is the only way to deal with this pandemic. Methods: A retrospective cross-sectional study was conducted in Pakistan in April 2020. Data was collected by Google statistics and percent reliability was calculated through SPSS. Results: The number of respondents n=678, out of which 443(65.2%) were female and 235(34.85%) were male. The perception of students regarding this disease is shown in a table in which 33.2% of students consider it very dangerous. 54.2% thought it moderately dangerous. 62.38% of students consider muscle pain and 73.59% of students consider throat pain as a clinical presentation of COVID-19. 80.7% of students thought that exposure to a suspected case of COVID-19 serves as a means of acquiring COVID-19 infection. The most effective measure of prevention comes out to be hand washing and covering face during coughing and sneezing. The main cause of the spread is a lack of public awareness and cooperation. Social media campaigns are an effective means of educating students about quarantine and controlling its rapid spread. Conclusion: Researchers concluded that It’s the need of the hour to increase awareness related to protective hygienic measures, rapid spread, and providing reliable approaches through social media campaigns to manage this pandemic. We believe that students should be involved in educating their surrounding society.
Weiss SR, Navas-Martin S. Coronavirus pathogenesis, and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev.. 2005;69(4):635-64.
Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-151. Chinese. Available from: doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. Available from: doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
WHO. Rolling updates on coronavirus disease (COVID-19)[Internet]. 2020[accessed on 2020 Mar 18]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Javaid S, Javaid MK. Survey on Corona Virus: A Case Study in Pakistan. IJMSCRR. 2020;3(02,):223-7
COVID-19 situation in Pakistan[Internet]. 2020[accessed on 2020 Jun 19]. Available from: http://covid.gov.pk/stats/pakistan
Nafees M, Khan F. Pakistan’s Response to COVID-19 Pandemic and Efficacy of Quarantine and Partial Lockdown: A Review. Electron J Gen Med. 2020; 17 (6): em240
D’Antiga L. Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic. Liver Transpl. 2020;26(6):832-834. Available from: doi: 10.1002/lt.25756. Epub 2020 Apr 24.
Kakodkar P, Kaka N, Baig MN. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). Cureus. 2020;12(4):e7560. Available from: doi: 10.7759/cureus.7560.
Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. Available from: doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
Asaad A, El-Sokkary R, Alzamanan M, El-Shafei M. Knowledge and attitudes towards Middle East respiratory sydrome-coronavirus (MERS-CoV) among health care workers in south-western Saudi Arabia. East Mediterr Health J. 2020 Apr 16;26(4):435-442. Available from: doi: 10.26719/emhj.19.079.
Watkins J. Preventing a covid-19 pandemic. BMJ. 2020;368:m810. Available from: doi: 10.1136/bmj.m810.
Alanzi ME, Albalawi MA, Kabrah S, Aljehani YT, Okashah AM, Aljohani ZD, Alribyawi RI, Alluqmany SA, Alanzi KE, Alanazi NE, Eltahlawi RA. Knowledge, Attitudes, and Practices (KAPs) of Healthcare Workers towards MERS-CoV Infection at PHCs in Madinah, KSA during Hajj 1440, 2019. Am J Microbiol Res. 2019;7(4):122-9.
Silversides A. Connection and communication vital to handling a pandemic in Ontario. CMAJ. 2007;176(5):614-5. Available from: doi: 10.1503/cmaj.070184.
Waris A, Atta UK, Ali M, Asmat A, Baset A. COVID-19 outbreak: current scenario of Pakistan. New Microbes New Infect. 2020;35:100681. Available from: doi: 10.1016/j.nmni.2020.100681.
Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72-73. Available from: doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
Ahmed SF, Quadeer AA, McKay MR. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses. 2020;12(3):254. Available from: doi: 10.3390/v12030254.
Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38(1):1-9. Available from: doi: 10.12932/AP-200220-0772.
Molina JM, Delaugerre C, Le Goff J, Mela-Lima B, Ponscarme D, Goldwirt L, de Castro N. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Med Mal Infect. 2020;50(384):30085-8.
Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020;117(17):9490-9496. Available from: doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.
Tian H, Liu Y, Li Y, Wu CH, Chen B, Kraemer MU, Li B, Cai J, Xu B, Yang Q, Wang B. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science. 2020;368(6491):638-42.
Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395(10228):931-934. Available from: doi: 10.1016/S0140-6736(20)30567-5. Epub 2020 Mar 9.
Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P. Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes Metab Syndr. 2020;14(4):367-382. Available from: doi: 10.1016/j.dsx.2020.04.015. Epub 2020 Apr 16.
Nussbaumer-Streit B, Mayr V, Dobrescu AI, Chapman A, Persad E, Klerings I, Wagner G, Siebert U, Christof C, Zachariah C, Gartlehner G. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database Syst Rev. 2020;4(4):CD013574. Available from: doi: 10.1002/14651858.CD013574.
Rajkumar RP. COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr. 2020;52:102066. Available from: doi: 10.1016/j.ajp.2020.102066.
How to Cite
Copyright (c) 2020 Hina Gul, Aasha Ijaz, Atiqa Khalid, Tabinda Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Under CC-BY Liscence, you are free to
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- for any purpose, even commercially.
Please cite the author everytime you share. Thank You